let-7 Control of LEF1 in Hematopoietic Progenitors Is an RBP-Gated, Indirect Axis

Question: How do let-7 miRNA-mediated post-transcriptional circuits regulate Wnt/β-catenin pathway components such as LEF1/TCF in hematopoietic stem and progenitor cells?

Answer

Across the retrieved papers, the only mechanistically specified let-7 circuit touching a Wnt/β-catenin effector in hematopoietic cells is LIN28B→let-7→LEF1: LIN28B, the oncofetal RNA-binding protein, regulates Wnt/β-catenin signalling "through post-transcriptional modulation of LEF1 via a let7 miRNA-mediated mechanism" [3]. β-catenin participates in this circuit as an RNA-associated scaffold rather than as a direct RNA binder — its crosslinking capacity for RNA is limited, while its associated mRNAs are enriched for the GGAG motif recognized by LIN28B — so the pathway is RBP-dependent [2] [3]. A parallel, let-7-independent RBP input (MSI2) converges on the same effector, suppressing LEF-1 expression and nuclear localization and reducing TCF/LEF output [2]. Critically, no retrieved paper demonstrates let-7 seed pairing to LEF1 or TCF7L2 3'UTRs in HSPCs, so the defensible position is that let-7 operates as a gated node inside an RBP-dominated post-transcriptional network rather than as a standalone repressor of LEF1/TCF.

The demonstrated let-7 arm is defined by LIN28B availability, not by a characterised let-7:LEF1 interaction

LIN28B was identified as the most plausible upstream regulator because the GGAG motif it recognizes was the most frequent RBP-binding motif among β-catenin-bound mRNAs [3]. The β-catenin–LIN28B interaction was detected in myeloid and lymphoid lines and in primary human CD34+ fetal-liver-derived HSCs [3]. In patient-derived data, LIN28B and LEF1 correlate within abnormal JMML HSPCs enriched in high-risk hypermethylated subgroups characterised by oncofetal gene expression [3]. Notably, the abstract attributes LEF1 modulation to "a let7 miRNA-mediated mechanism" without reporting a LEF1 3'UTR reporter, seed mutagenesis, or AGO2 CLIP at that locus — the let-7 step is inferred from the LIN28B node, which is exactly the inferential gap this circuit's literature currently rests on.

β-catenin is a scaffold in this circuit, and its Wnt output is 3'UTR-dependent but abundance-independent

β-catenin RIP-seq recovered significantly enriched Wnt pathway transcripts, yet CLIP showed only limited direct RNA binding, implying dependence on other RBPs [2]. Separately, partial deletion of the endogenous CTNNB1 3'UTR leaves β-catenin protein levels unaffected but impairs induction of the Wnt transcriptional program during human stem cell differentiation, because intermolecular 3'UTR–3'UTR interactions between Wnt transcription factor mRNAs and CTNNB1 enable co-translational assembly of these factors with β-catenin [7]. Together these results reframe "let-7 regulation of LEF1" as potentially a control on the assembly-competent pool of LEF1 rather than on LEF1 abundance — a distinction no retrieved paper tests directly.

MSI2 is a second, let-7-independent RBP input converging on LEF1 and on HSPC expansion

MSI2 knockdown reduced TCF/LEF activity through suppression of LEF-1 expression and nuclear localization, and MSI2 binds LEF1 mRNA in a partly β-catenin-dependent fashion [2]. MSI2-mediated expansion of human HSPCs could be partly driven through LEF1 regulation [2]. Genetic evidence ties this node to stem cell fitness: the non-coding variant rs17834140-T protects against clonal hematopoiesis and myeloid malignancy by downregulating HSC-selective MSI2 expression and function, mapping an RNA network that maintains human HSCs [8]. MSI2 activity is itself compartment-specified: the canonical MSI2-328 isoform promotes translation without changing mRNA abundance and localises cytoplasmically, whereas the alternatively spliced MSI2-324 isoform is predominantly nuclear and fails to promote translation [9]. Because Wagstaff et al. score LEF-1 nuclear localisation as a readout, isoform composition is an unexcluded confounder in the very assay used to define the axis.

The circuit's sign is not fixed: let-7 is not a pure differentiation brake, and LIN28B/let-7 is a double-negative loop

let-7 family members are conventionally linked to differentiation, but miR-98-5p promotes naive induction by repressing NR6A1 while transiently activating BMP2/4 signalling, destabilising the primed network [1]. This makes "let-7 up ⇒ LEF1/TCF down ⇒ differentiation" an unsafe default in a stem cell context. The upstream node is also self-reinforcing: K-Ras negatively regulates let-7b via ERK and LIN28B, forming a reciprocal feedback loop [10]. A LIN28B-high, let-7-low HSPC state is therefore expected to be LEF1-high, and the oncofetal reactivation described in JMML is consistent with that prediction [3].

Transcriptional cross-repression between LEF1 and TCF7L2 can mask or mimic post-transcriptional control

Loss of TCF4 (TCF7L2) function results in over-expression of LEF1, which is transcriptionally competent and over-compensates for TCF4 silencing in a Wnt reporter assay; TCF4 enlists CtBP1 and binds the LEF1 promoter, indicating direct repression [6]. Any let-7- or MSI2-driven change in LEF1 protein therefore feeds back on TCF4-driven output and vice versa, so bulk TCF/LEF reporter activity cannot be attributed to post-transcriptional control alone [2] [6]. That miRNAs can control Wnt components in CD34+ progenitors at all is established — HCMV miR-US5-2 and miR-US25-2 downregulate the Wnt adaptor Dvl3 during latency in CD34+ HPCs [4] — but that is viral, not let-7, and targets a different pathway node.

Conflicts and gaps

The central conflict is between a named mechanism and a demonstrated one: Sevim et al. assign LEF1 control to a let-7-mediated mechanism [3] while the companion mechanistic work attributes LEF1 suppression to MSI2 binding and nuclear localisation [2], and neither paper tests whether let-7 sites in the LEF1 3'UTR are occupied. Whether TCF7L2/TCF4 is a let-7 target is entirely untested in these papers. let-7 family member specificity is unresolved: in a systematic survey, only let-7a-3p and let-7g-3p strongly downregulated OGT, and repression required two seed-dependent sites [5] — implying single-site predictions for LEF1 are weak evidence. Target-site identification is further complicated by functional 3'-only sites lacking seed complementarity [11] and by RBPs that directly compete with AGO2-miRNA complexes for 3'UTR binding [12], a mechanism that could produce LIN28B- or MSI2-dependent LEF1 changes without any change in let-7 targeting. Cell-type coverage is also thin and non-overlapping: AML lines and patient samples [2], JMML HSPCs [3], clonal hematopoiesis genetics [8], and colon cancer for the LEF1/TCF4 feedback [6].

What would change the answer

A direct test requires AGO2 miR-eCLIP or CLIP in primary human CD34+ HSPCs with chimeric miRNA–mRNA reads at the LEF1 and TCF7L2 3'UTRs, paired with 3'UTR reporters carrying mutated let-7 seed sites and with LNA-mediated let-7 inhibition read out at endogenous LEF1 protein and nuclear fraction. Acute degron depletion of LIN28B and of MSI2, with and without let-7 mimics, would separate let-7-dependent from RBP-occlusion mechanisms. Allele-specific or single-cell reporter approaches would disentangle post-transcriptional LEF1 control from TCF4-mediated transcriptional repression [6]. Finally, isoform-resolved MSI2 perturbation [9] and 3'UTR-interaction blockade [7] would establish whether the functional let-7 output is LEF1 abundance or LEF1–β-catenin assembly competence.

References

[1] Fujita, Y., Hirosawa, M., Hayashi, K., Ono, H., Kaswandy, B., Ueda, M., Lopez, M., Yamamoto, T., Takashima, Y., Saito, H.. "Transient let-7/miR-98 reprograms primed pluripotency to induce naivehuman PSCs". bioRxiv. 2025-10-15T00:00:00.000Z. URL: https://doi.org/10.1101/2025.10.14.682465

[2] Wagstaff, M., Sevim, O., Goff, A., Raynor, M., Park, H., Mancini, E., Nguyen, D. T., Chevassut, T., Blair, A., Castellano, L., Newbury, S. F., Towler, B. P., Morgan, R. G.. "β-Catenin associates with a Wnt signaling mRNA network in myeloid cells through canonical RBP binding.". bioRxiv. 2024-12-16T00:00:00.000Z. URL: https://doi.org/10.1101/2024.01.28.577638

[3] Sevim, O., Wagstaff, M., Ling, R. E., Goff, A., Palmer, D. A., Park, H., Hills, K., Castellano, L., Newbury, S. F., Roy, A., Towler, B. P., Morgan, R. G.. "LIN28B is a post-transcriptional regulator of Wnt signalling in myeloid leukemia cells and dual targeting promotes cytotoxicity". bioRxiv. 2026-10-19T00:00:00.000Z. URL: https://doi.org/10.64898/2026.01.25.698240

[4] Diggins, N., Slind, L. E., Mitchell, J., Pham, A., Fachko, D. N., Chen, Y., Turner, R., Caposio, P., Skalsky, R. L., Hancock, M. H.. "Human cytomegalovirus microRNAs target the Wnt signaling protein Dishevelled 3 to promote efficient reactivation in CD34+ hematopoietic progenitor cells". bioRxiv. 2026-10-19T00:00:00.000Z. URL: https://doi.org/10.64898/2026.10.18.759990

[5] Ali, S. Z., Jame-Chenarboo, F., Ng, H.-H., Thu, C., Dehghan Harati, H., Macdonald, D., Mahal, L. K.. "Analyzing the miRNA regulatory landscape of OGT identifies evolutionarily conserved upregulation.". bioRxiv. 2025-08-24T00:00:00.000Z. URL: https://doi.org/10.1101/2025.08.21.671361

[6] Brown, M. A., Yaghoubi, S., Kamlah, J., Chen, W.-D., Zong, D., Khorasani, S. T., Zhan, T., Boutros, M., Polo, J. C., Meltzer, P. S.. "TCF4 and CtBP1 Repress LEF1 to Maintain a TCF4-centric Transcriptional Program in Colon Cancer.". bioRxiv. 2026-09-28T00:00:00.000Z. URL: https://doi.org/10.64898/2026.09.25.751839

[7] Cai, T., Cruz, N. M., Basu, S., White, R. M., Mayr, C.. "Intermolecular 3'UTR-3'UTR interactions drive Wnt gene activation through heteromeric protein assembly". bioRxiv. 2026-05-07T00:00:00.000Z. URL: https://doi.org/10.64898/2026.05.05.723075

[8] Agarwal, G., Antoszewski, M., Xie, X., Pershad, Y., Arora, U. P., Poon, C.-L., Lyu, P., Lee, A. J., Guo, C.-J., Ye, T., Norford, L. B., Neehus, A.-L., della Volpe, L., Wahlster, L., Ranasinghe, D., Ho, T.-C., Barlowe, T. S., Chow, A., Schurer, A., Taggart, J., Durham, B. H., Abdel-Wahab, O., McGraw, K. L., Allan, J. M., Soldatov, R., Bick, A. G., Kharas, M. G., Sankaran, V. G.. "Inherited resilience to clonal hematopoiesis by modifying stem cell RNA regulation". bioRxiv. 2025-03-26T00:00:00.000Z. URL: https://doi.org/10.1101/2025.03.24.645017

[9] Walters, K., Koertel, N., Baldwin, A., Sajek, M. P., Mukherjee, N.. "Isoform-Specific Localization Diversifies Human MSI2 Function". bioRxiv. 2026-05-18T00:00:00.000Z. URL: https://doi.org/10.64898/2026.05.16.725683

[10] Liang, Z., Yi, B., Ma, R., Riker, A. I., Xi, Y.. "Sulindac Sulfide Suppresses Oncogenic Transformation Through let-7b-Mediated Repression of K-Ras Signaling". bioRxiv. 2025-06-23T00:00:00.000Z. URL: https://doi.org/10.1101/2025.06.21.660893

[11] Hall, M. H., Wang, P. Y., Pham, T. M., Bartel, D. P.. "Functional microRNA targeting without seed pairing". bioRxiv. 2025-03-11T00:00:00.000Z. URL: https://doi.org/10.1101/2025.03.03.641270

[12] Kabbani, L. E., Kapoor, S., Sharma, G. E., Gutierrez, M., Neeb, Z. T., Jaiswal, A., Ritter, A. J., Katzman, S., Feldman, J. E., Rao, D. S., Sanford, J. S.. "IGF2BP3 remodels the microRNA targeting landscape in MLL-AF4 leukemia". bioRxiv. 2025-10-13T00:00:00.000Z. URL: https://doi.org/10.1101/2025.10.10.681741